UNSPSC 85893945: High dose rate (hdr) brachytherapy of cervix using cesium 137 (cs-137)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of cervix using cesium 137 (cs-137). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DU1197Z

UNSPSC 85893945 High dose rate brachytherapy of cervix using cesium 137, a Commodity code, shows minimal alignment with the recent state and local procurement activity tagged under it. The single recent opportunity — Santa Clara County Health System's RFQ for temporary health professional staffing services (RFSQHHSFY270052, due October 7, 2026) — covers ancillary clinical placement including audiology, radiology, respiratory care, surgical operating room, and therapy services, but does not involve brachytherapy, radiation oncology, or any cancer treatment modalities. The mismatch suggests either miscoding in the county's procurement system or a data labeling error; the solicitation itself is a multi-category staffing qualification vehicle with no guaranteed work volume and no fixed contract values, designed to build a qualified vendor pool for ad-hoc temporary placements rather than procure a specific clinical service line or technology.

The code shows no other recent state or local contract opportunities in the source and no documented activity across multiple jurisdictions or geographic regions. Without additional opportunities properly tagged under this Commodity code, there is insufficient evidence to characterize issuing-body patterns, geographic concentration, or realistic market demand for brachytherapy services at the state and local level. A business development professional evaluating this code should treat it as currently inactive for practical procurement purposes and verify whether the Santa Clara County posting represents a genuine data error or if state and local health systems have shifted procurement of radiation oncology services to alternative sourcing channels or vendor relationships not reflected in posted notices.